Creatures

Cn /En

New drug development services

CDC

Welcome to ourCDCIn vitro immune-tumor cell co-culture killing experimental platform. This platform is specifically designed for studying complement-dependent cytotoxicity and can provide you with the latest solutions for quantitative analysis of monoclonal antibody-induced complement-dependent toxicity.
Target cell selection:
• We offer a variety of options, including tumor cell lines, primary tumor cells, and genetically engineered cell lines to meet your different research needs.
Effector cell supply:
• According to your experimental needs, we support the use of commercially sourced PBMCs, and we also provide PBMCs from clinical patients. Our team will recommend the most suitable effector cell population based on the specific needs of new drug development.
Analysis and detection:
• We use flow cytometry technology to effectively distinguish target cells, accurately count, and calculate the proportion of apoptotic cells, providing you with accurate and reliable data support.
• Additionally, to comprehensively assess the experimental effects, we also provide the LDH method to detect the activity of tumor cells.
On this platform, we are committed to providing you with the most professional and efficient services to help your research achieve significant breakthroughs. We welcome cooperation with you!


Validate the in vitro CDC efficacy of Rituximab on Raji cells.

Chuangmo Biotechnology (Beijing) Co., Ltd.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Chuangmo Biotechnology (Beijing) Co., Ltd

SEO

Powered by：CEglobal

Business License